LCN2 and acute kidney injury: This provides the advantage of identifying patients with subclinical AKI who may be overlooked based on serum creatinine levels, such as 43% of patients in one study diagnosed with AKI using NGAL who would not have been diagnosed using serum creatinine alone [13].